Precision de-escalation in HER2-enriched breast cancer: promise and pitfalls of multiomic response predictors.

da Silva JL, de Melo AC

Open source

DOI
10.21037/tbcr-2026-0032
Published
2026
Container
Translational breast cancer research : a journal focusing on translational research in breast cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21037/tbcr-2026-0032,
  title = {Precision de-escalation in HER2-enriched breast cancer: promise and pitfalls of multiomic response predictors.},
  author = {da Silva JL and de Melo AC},
  year = {2026},
  journal = {Translational breast cancer research : a journal focusing on translational research in breast cancer},
  doi = {10.21037/tbcr-2026-0032},
  url = {https://doi.org/10.21037/tbcr-2026-0032}
}

RIS

TY  - JOUR
TI  - Precision de-escalation in HER2-enriched breast cancer: promise and pitfalls of multiomic response predictors.
AU  - da Silva JL
AU  - de Melo AC
PY  - 2026
JO  - Translational breast cancer research : a journal focusing on translational research in breast cancer
DO  - 10.21037/tbcr-2026-0032
UR  - https://doi.org/10.21037/tbcr-2026-0032
ER  - 

APA

JL, D. S., & AC, D. M. (2026). Precision de-escalation in HER2-enriched breast cancer: promise and pitfalls of multiomic response predictors.. Translational breast cancer research : a journal focusing on translational research in breast cancer. https://doi.org/10.21037/tbcr-2026-0032

Source records